SLS Stock Analysis: Buy, Sell, or Hold?
SLS - SELLAS Life Sciences Group, Inc. Common Stock
$7.11
0.58 (8.81%)
▲
5d:
+44.12%
30d:
+44.7%
90d:
+100.14%
WAIT
LOW Confidence
Analysis Updated: May 13, 2026 12:00 AM ET
Earnings: May 19, 2026
4d
Smart Money Accumulation
SLS is down 5.3% this week, but smart money is accumulating calls. Top strike: $4 2026-07-17 with 20,503 OI. Call ratio: 97% View Scanner →
Strength: 7.0/10
Get Alerted When SLS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
133 traders called SLS this week
81% bullish • 56 bearish
81% bullish • 56 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: SLS is 28.5% above its trading range ($5.53). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: SLS is 28.5% above its trading range ($5.53). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: SLS is currently trading at $7.11, which is considered extended relative to its 30-day fair value range of $4.51 to $5.53.
Technical Outlook: Technically, SLS is in a uptrend. The price is approaching resistance at $7.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.8% recently.
Market Sentiment: SLS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+53.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SLS is in a uptrend. The price is approaching resistance at $7.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.8% recently.
Market Sentiment: SLS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+53.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.51 -
$5.53
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
SLS is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+28.5% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.8%)
- BULLISH: Trading 53.1% below Wall St target ($10.00)
- WARNING: Recommendation downgraded due to 28.5% overvaluation
Trading Range Analysis
30-Day Trading Range
$4.51 -
$5.53
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.83
Resistance Level
$7.19
Current Trend
Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-40.81
Wall Street Target
$10.00
(+53.1%)
Revenue Growth (YoY)
-82.5%
Share & Embed Analysis
Last updated: May 14, 2026 12:44 PM ET
Data refreshes hourly during market hours. Next update: 1:44 PM
Data refreshes hourly during market hours. Next update: 1:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Katherine Bach Kalin
BUY
63400 shares
2025-11-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 56 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$130 | 54 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 55 HOLD |
Advanced SLS Option Strategies
Professional options setups generated by AI based on today's SLS price and gamma walls.
